• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 准种为流行变异株提供了有利的突变库。

SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.

机构信息

Department of Infectious Diseases, Southwest Hospital, Third Military Medical Universitygrid.410570.7 (Army Medial University), Chongqing, China.

Chongqing Key Laboratory for Research of Infectious Diseases, Chongqing, China.

出版信息

Microbiol Spectr. 2021 Sep 3;9(1):e0026121. doi: 10.1128/Spectrum.00261-21. Epub 2021 Aug 4.

DOI:10.1128/Spectrum.00261-21
PMID:34346744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8552775/
Abstract

The dynamics of quasispecies afford RNA viruses a great fitness on cell tropism and host range. To study the quasispecies features and the intra-host evolution of SARS-CoV-2, we collected nine confirmed patients and sequenced the haplotypes of spike gene using a single-molecule real-time platform. Fourteen samples were extracted from sputum, nasopharyngeal swabs, or stool, which in total produced 283,655 high-quality circular consensus sequences. We observed a stable quasispecies structure that one master mutant (mean abundance ∼0.70), followed by numerous minor mutants (mean abundance ∼1.21 × 10). Under high selective pressure, minor mutants may obtain a fitness advantage and become the master ones. The later predominant substitution D614G existed in the minor mutants of more than one early patient. An epidemic variant had a possibility to be independently originated from multiple hosts. The mutant spectrums covered ∼85% amino acid variations of public genomes (GISAID; frequency ≥ 0.1) and likely provided an advantage mutation pool for the current/future epidemic variants. Notably, 32 of 35 collected antibody escape substitutions were preexistent in the early quasispecies. Virus populations in different tissues/organs revealed potentially independent replications. The quasispecies complexity of sputum samples was significantly lower than that of nasopharyngeal swabs ( = 0.02). Evolution analysis revealed that three continuous S2 domains (HR1, CH, and CD) had undergone a positive selection. Cell fusion-related domains may play a crucial role in adapting to the intrahost immune system. Our findings suggested that future epidemiologic investigations and clinical interventions should consider the quasispecies information that has missed by routine single consensus genome. RNA virus population in a host does not consist of a consensus single haplotype but rather an ensemble of related sequences termed quasispecies. The dynamics of quasispecies afford SARS-CoV-2 a great ability on genetic fitness during intrahost evolution. The process is likely achieved by changing the genetic characteristics of key functional genes, such as the spike glycoprotein. Previous studies have applied the next-generation sequencing (NGS) technology to evaluate the quasispecies of SARS-CoV-2, and results indicated a low genetic diversity of the spike gene. However, the NGS platform cannot directly obtain the full haplotypes without assembling, and it is also difficult to predict the extremely low-frequency variations. Therefore, we introduced a single-molecule real-time technology to directly obtain the haplotypes of the RNA population and further study the quasispecies features and intrahost evolution of the spike gene.

摘要

病毒准种为 RNA 病毒提供了对细胞嗜性和宿主范围的巨大适应性。为了研究 SARS-CoV-2 的准种特征和宿主内进化,我们收集了 9 名确诊患者的样本,并使用单分子实时平台对刺突基因的单倍型进行测序。从痰、鼻咽拭子或粪便中提取了 14 个样本,总共产生了 283655 个高质量的环状一致序列。我们观察到一个稳定的准种结构,一个主要突变体(平均丰度约为 0.70),其次是许多次要突变体(平均丰度约为 1.21×10)。在高选择压力下,次要突变体可能获得适应性优势并成为主要突变体。后来主要的替代 D614G 存在于一个以上早期患者的次要突变体中。流行变体有可能独立起源于多个宿主。突变谱涵盖了公共基因组(GISAID;频率≥0.1)中约 85%的氨基酸变异,可能为当前/未来的流行变体提供了有利的突变池。值得注意的是,35 个收集到的抗体逃逸突变中有 32 个在早期准种中就已经存在。不同组织/器官中的病毒群体显示出潜在的独立复制。痰样本的准种复杂性明显低于鼻咽拭子(=0.02)。进化分析表明,连续的 S2 结构域(HR1、CH 和 CD)经历了正选择。细胞融合相关结构域可能在适应宿主内免疫系统方面发挥关键作用。我们的研究结果表明,未来的流行病学调查和临床干预应考虑常规单一致基因组遗漏的准种信息。宿主中的 RNA 病毒群体不是由共识单倍型组成,而是由相关序列组成的集合,称为准种。准种动态为 SARS-CoV-2 提供了在宿主内进化过程中遗传适应性的巨大能力。这一过程可能是通过改变关键功能基因(如刺突糖蛋白)的遗传特征来实现的。先前的研究已经应用下一代测序(NGS)技术来评估 SARS-CoV-2 的准种,结果表明刺突基因的遗传多样性较低。然而,NGS 平台在不进行组装的情况下无法直接获得完整的单倍型,也很难预测极低频率的变异。因此,我们引入了单分子实时技术来直接获得 RNA 群体的单倍型,并进一步研究刺突基因的准种特征和宿主内进化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/e57ac82ff2c1/spectrum.00261-21-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/3e3a658685f5/spectrum.00261-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/b62212c4abbe/spectrum.00261-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/bc035fd6bc23/spectrum.00261-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/19d50bbef1f1/spectrum.00261-21-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/d2801e7419ec/spectrum.00261-21-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/e57ac82ff2c1/spectrum.00261-21-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/3e3a658685f5/spectrum.00261-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/b62212c4abbe/spectrum.00261-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/bc035fd6bc23/spectrum.00261-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/19d50bbef1f1/spectrum.00261-21-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/d2801e7419ec/spectrum.00261-21-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9077/8552775/e57ac82ff2c1/spectrum.00261-21-f006.jpg

相似文献

1
SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.SARS-CoV-2 准种为流行变异株提供了有利的突变库。
Microbiol Spectr. 2021 Sep 3;9(1):e0026121. doi: 10.1128/Spectrum.00261-21. Epub 2021 Aug 4.
2
Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.鉴定具有增强致细胞病变和融合作用的 SARS-CoV-2 高频宿主内刺突变异株。
mBio. 2021 Jun 29;12(3):e0078821. doi: 10.1128/mBio.00788-21.
3
Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia.宿主内 SARS-CoV-2 的多样性不容忽视:以澳大利亚维多利亚州为例。
Viruses. 2021 Jan 19;13(1):133. doi: 10.3390/v13010133.
4
"Outlaw" mutations in quasispecies of SARS-CoV-2 inhibit replication.“违禁”突变会抑制 SARS-CoV-2 准种的复制。
Emerg Microbes Infect. 2024 Dec;13(1):2368211. doi: 10.1080/22221751.2024.2368211. Epub 2024 Jun 25.
5
Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis.SARS-CoV-2 准种的单核苷酸多态性(SNPs)分析揭示。
Virulence. 2021 Dec;12(1):1209-1226. doi: 10.1080/21505594.2021.1911477.
6
Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.两步策略测序揭示突尼斯高传播期后 SARS-CoV-2 S 基因的高遗传多样性。
Microbiol Spectr. 2021 Dec 22;9(3):e0063921. doi: 10.1128/Spectrum.00639-21. Epub 2021 Nov 10.
7
Quasispecies Analysis of SARS-CoV-2 of 15 Different Lineages during the First Year of the Pandemic Prompts Scratching under the Surface of Consensus Genome Sequences.大流行第一年中 15 种不同谱系的 SARS-CoV-2 的准种分析促使人们对共识基因组序列进行深入研究。
Int J Mol Sci. 2022 Dec 10;23(24):15658. doi: 10.3390/ijms232415658.
8
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.两种 SARS-CoV-2 欧洲谱系 20E 刺突突变的进化和表型特征。
mBio. 2021 Dec 21;12(6):e0231521. doi: 10.1128/mBio.02315-21. Epub 2021 Nov 16.
9
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates.大规模分析 SARS-CoV-2 刺突糖蛋白突变体表明需要持续筛选病毒分离物。
PLoS One. 2021 Sep 27;16(9):e0249254. doi: 10.1371/journal.pone.0249254. eCollection 2021.
10
Host-dependent editing of SARS-CoV-2 in COVID-19 patients.COVID-19 患者中 SARS-CoV-2 的宿主依赖性编辑。
Emerg Microbes Infect. 2021 Dec;10(1):1777-1789. doi: 10.1080/22221751.2021.1969868.

引用本文的文献

1
Evolution at Spike protein position 519 in SARS-CoV-2 facilitated adaptation to humans.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白第519位的进化促进了对人类的适应性。
Npj Viruses. 2024 Jul 9;2(1):29. doi: 10.1038/s44298-024-00036-2.
2
SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)生物克隆在基因上是异质的,并且包含进化枝不一致的残基。
J Virol. 2025 May 20;99(5):e0225024. doi: 10.1128/jvi.02250-24. Epub 2025 Apr 24.
3
Within-Host Fitness and Antigenicity Shift Are Key Factors Influencing the Prevalence of Within-Host Variations in the SARS-CoV-2 Gene.

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.社区检出的 SARS-CoV-2 谱系 B.1.1.7 病例死亡率增加。
Nature. 2021 May;593(7858):270-274. doi: 10.1038/s41586-021-03426-1. Epub 2021 Mar 15.
3
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.在英格兰,估计 SARS-CoV-2 谱系 B.1.1.7 的传染性和影响。
宿主内适应性和抗原性转变是影响严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因宿主内变异流行率的关键因素。
Viruses. 2025 Mar 2;17(3):362. doi: 10.3390/v17030362.
4
Tracking cryptic SARS-CoV-2 hospital outbreak through quasispecies analysis.通过准种分析追踪隐匿的新冠病毒医院内暴发情况。
Virol J. 2024 Dec 21;21(1):331. doi: 10.1186/s12985-024-02609-2.
5
A general and biomedical perspective of viral quasispecies.病毒准种的综合与生物医学视角。
RNA. 2025 Feb 19;31(3):429-443. doi: 10.1261/rna.080280.124.
6
Positive selection, genetic recombination, and intra-host evolution in novel equine coronavirus genomes and other members of the subgenus.新型马冠状病毒基因组和亚科其他成员中的正选择、遗传重组和宿主内进化。
Microbiol Spectr. 2024 Nov 5;12(11):e0086724. doi: 10.1128/spectrum.00867-24. Epub 2024 Oct 7.
7
Evaluation of RNA Secondary Stem-Loop Structures in the UTRs of Mouse Hepatitis Virus as New Therapeutic Targets.评估小鼠肝炎病毒非翻译区中的RNA二级茎环结构作为新的治疗靶点
Pathogens. 2024 Jun 19;13(6):518. doi: 10.3390/pathogens13060518.
8
SARS-CoV-2 mutant spectra as variant of concern nurseries: endless variation?作为关注变异株温床的新型冠状病毒2突变谱:变异无穷?
Front Microbiol. 2024 Mar 14;15:1358258. doi: 10.3389/fmicb.2024.1358258. eCollection 2024.
9
Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.通过神经网络单倍型图谱识别出 SARS-CoV-2 功能分化初期。
Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2317851121. doi: 10.1073/pnas.2317851121. Epub 2024 Feb 28.
10
SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice.当 SARS-CoV-2 在免疫幼稚的小鼠中反复传代时,会迅速进化出谱系特异性的表型差异。
Commun Biol. 2024 Feb 16;7(1):191. doi: 10.1038/s42003-024-05878-3.
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
4
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.预测用于治疗 COVID-19 的抗体所识别的病毒突变逃逸情况。
Science. 2021 Feb 19;371(6531):850-854. doi: 10.1126/science.abf9302. Epub 2021 Jan 25.
5
COVID-19 vaccines: where we stand and challenges ahead.COVID-19 疫苗:我们的现状和未来的挑战。
Cell Death Differ. 2021 Feb;28(2):626-639. doi: 10.1038/s41418-020-00720-9. Epub 2021 Jan 21.
6
Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia.宿主内 SARS-CoV-2 的多样性不容忽视:以澳大利亚维多利亚州为例。
Viruses. 2021 Jan 19;13(1):133. doi: 10.3390/v13010133.
7
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity.对印度新冠病毒基因组的分析揭示了刺突蛋白中D614G突变的流行情况,该突变预示着与跨膜丝氨酸蛋白酶2(TMPRSS2)的相互作用增加以及病毒传染性增强。
Front Microbiol. 2020 Nov 23;11:594928. doi: 10.3389/fmicb.2020.594928. eCollection 2020.
8
An update on the global vaccine development for coronavirus.冠状病毒全球疫苗研发的最新情况。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2053-2055. doi: 10.1016/j.dsx.2020.10.023. Epub 2020 Oct 23.
9
COVID-19: Discovery, diagnostics and drug development.新型冠状病毒肺炎:发现、诊断和药物研发。
J Hepatol. 2021 Jan;74(1):168-184. doi: 10.1016/j.jhep.2020.09.031. Epub 2020 Oct 8.
10
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.基于结构导向的高分辨率血清学方法绘制 SARS-CoV-2 刺突受体结合域上的中和和免疫优势位点
Cell. 2020 Nov 12;183(4):1024-1042.e21. doi: 10.1016/j.cell.2020.09.037. Epub 2020 Sep 16.